BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19436230)

  • 1. Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases.
    Mihailovic JM; Stefanovic LJ; Malesevic MD; Erak MD; Tesanovic DD
    Nucl Med Commun; 2009 Jul; 30(7):558-64. PubMed ID: 19436230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
    Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
    J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
    Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
    J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
    Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
    Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
    Lee J; Soh EY
    Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases.
    Mihailovic J; Stefanovic L; Malesevic M; Markoski B
    Thyroid; 2009 Mar; 19(3):227-32. PubMed ID: 19265493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results in elderly patients with differentiated thyroid carcinoma.
    Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
    Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma.
    Sugino K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Kameyama K; Ito K
    Thyroid; 2011 Jul; 21(7):751-7. PubMed ID: 21615311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
    Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
    Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
    J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes.
    Mihailovic J; Nikoletic K; Srbovan D
    J Nucl Med; 2014 May; 55(5):710-7. PubMed ID: 24722527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung metastases from differentiated thyroid carcinoma. A 40 years' experience.
    Ronga G; Filesi M; Montesano T; Di Nicola AD; Pace C; Travascio L; Ventroni G; Antonaci A; Vestri AR
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):12-9. PubMed ID: 15194999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated thyroid carcinoma with distant metastases: probability of survival and its predicting factors.
    Mihailovic J; Stefanovic L; Malesevic M
    Cancer Biother Radiopharm; 2007 Apr; 22(2):250-5. PubMed ID: 17600472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid.
    Podnos YD; Smith D; Wagman LD; Ellenhorn JD
    Surgery; 2005 Dec; 138(6):1072-6; discussion 1076-7. PubMed ID: 16360393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of initial treatment on the survival and recurrence in patients with differentiated thyroid microcarcinoma.
    Mihailovic J; Stefanovic L; Stankovic R
    Clin Nucl Med; 2013 May; 38(5):332-8. PubMed ID: 23486336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.